Loxo Oncology Inc. (LOXO) Has Jumped To A New High On Study Results

Loxo Oncology Inc. (LOXO) announced after the bell Wednesday that preliminary results from a Phase 1 trial showed that its LOXO-292 drug shrank tumors in nearly 70 percent of patients.

from RTT - Hot Stocks https://ift.tt/2rQ1FwI
via IFTTT